Share the article

A large number of successful women turn to our company. Many people wonder how these women succeeded. And I will tell you the answer! Women did not give up. Women were looking for different ways to make money. One woman told us that she won her first million dollars at online poker in a casino. Do you want to know what the most incredible winnings people have made? Then read the article carefully.

In focus

Launch of a new approach to antimicrobial stewardship in Zambia

At the yearly ReAct Africa Conference in Zambia in July, the Director General of the Zambia National Public Health Institute (ZNPHI) Professor Roma Chilengi, launched the Zambia Strategic Program for Antimicrobial Stewardship (ZASPARS). The program is an adaptation of the Swedish strategic programme against antibiotic resistance (STRAMA) which has led to a significant reduction of the inappropriate use of antibiotics in Sweden since its introduction in 1995.

ReAct - Action on Antibiotic Resistance

ReAct is an independent network dedicated to the problem of antibiotic resistance. ReAct is a global catalyst, advocating and stimulating for global engagement on antibiotic resistance through a broad range of collaborations.

News

Key takeaways from the ReAct Africa and South Centre Conference

The ReAct Africa and South Centre Annual conference was held as a hybrid event from 25-27 July in Lusaka Zambia under the theme: Africa’s response to Antimicrobial Resistance: Accelerating One Health National Action Plans implementation for the next 5 years. Participants from 30 countries joined the sessions and discussions. Find a few key takeaways from the 3-day conference.

Competition

Innovate4Health 2022: Call for student team applications!

Student?  Take the opportunity to join the front lines to act on antimicrobial resistance and COVID-19 in the Innovate4Health competition. This year, student teams are encouraged to innovate around three pillars: prevention and treatment, reduce use of antimicrobials in food systems and resilient community health systems. Deadline is 19 September.

Policy

New ReAct Europe and EPHA position paper on EU incentives for new antibiotics development

In a joint publication, ReAct Europe and the European Public Health Alliance (EPHA) express concerns as only a limited number of options for introducing incentives have been considered during the European Commission targeted consultations. The position paper includes 10 reasons why a TEE is not efficient for advancing antibiotic development.

In focus

Dr. Hari Paraton: Drug resistance bacteria threatens lives of mothers and newborn

In general, administering stitches to close tears on mothers who have newly delivered a child are a safe and common procedure. However, the handling of post-delivery sutures by health workers without sufficient understanding about the use of antibiotics and the risk of infection can be a different story. What are supposed to be happy moments for parents with their new born baby, after going through the delivery process, might sadly end in grief.

This was experienced by Dr Hari Paraton, an obstetrician and gynecologist from Surabaya, Indonesia, who handled a patient, (we will call her “Paramita”) with abnormal post-delivery stitches. Instead of drying out, the wound on the stitches just got worse and wider.

Policy

Allocation of adequate resources and community engagement key to NAP implementation

In 2015 recognizing the growing problem of antimicrobial resistance the World Health Organization endorsed a Global Action Plan on AMR.

The five objectives that the Global Action Plan aimed for were:

  • improving awareness and understanding of antimicrobial resistance,
  • strengthening surveillance and research,
  • reducing the incidence of infection,
  • optimizing the use of antimicrobial medicines in human and animal health and
  • ensuring sustainable investment in new medicines, diagnostic tools, vaccines, and other interventions.

How far along are we?

Research and development

The world needs new antibiotics – so why aren’t they developed?

Effective antibiotics are a cornerstone of basic and specialized medicine. The emergence of resistance in bacteria to antibiotics is slowly dismantling our ability to treat infections, alleviate human suffering, and save lives. The COVID-19 pandemic is a clear reminder of the deadly consequences the world faces, when we do not have the right treatments or vaccines available when needed.

Theme

COVID-19 and antibiotic resistance

ReAct articles relating to COVID-19 and antibiotic resistance.

Antibiotic resistance

In the last 70 years the use of antibiotics has been crucial in improving countless lives and drastically reducing deaths caused by bacterial infections. The increasing development of antibiotic resistance is posing a serious threat to human health and development, the environment and for animal health. Learn more about antibiotic resistance here.

Donate

Support us - your donation helps

Your gift means a great deal. With your donation you will help address antibiotic resistance.

We are global

ReAct is a global network of antibiotic resistance experts with nodes in Africa, Asia Pacific, Europe, Latin America and North America.

The ReAct Toolbox

The ReAct Toolbox is a user-friendly web-based resource that provides inspiration and guidance to take action and develop national action plans on antibiotic resistance. It is built on what has been done in the past in a variety of settings, and is aligned with ongoing and current initiatives from across the globe.

Stay on top of antibiotic resistance

Get our newsletter once a month to be updated on the latest research, policy news, ReAct global network activities and much more.
Past newsletters

National Action Plans

Involved in developing and implementing your country's National Action Plan on AMR? Here you find support tools and inspiration.

Movement Building

Engagement from civil society organizations and communities is needed to tackle antibiotic resistance. Learn more about how to get involved.

Globally Coordinated Governance

Globally coordinated governance on antimicrobial resistance - to ensures a sustainable response that takes into account the conditions for LMICs

Public Health Driven Innovation

A public health driven and end-to-end approach to innovation that enables sustainable access to effective antibiotics in LMICs